NCT02379624

Brief Summary

Acute lower gastrointestinal dysfunction is a kind of much common complication which occurred in critically ill patients. Once it developed, enteral nutrition would be disturbed. In this study, investigators suppose that early application of a sufficient amount of pectin ahead of enteral nutrition, may promote recovery of acute lower gastrointestinal dysfunction in critically ill patients, and exert its good effect on early EN support. Investigators designed this prospective randomized controlled trial to test and evaluates the effect whether EN feeding with or without a pectin start would be safe or with advanced clinical outcomes.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
125

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Aug 2014

Shorter than P25 for phase_1

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2014

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

August 30, 2014

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2015

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 5, 2015

Completed
Last Updated

March 5, 2015

Status Verified

February 1, 2015

Enrollment Period

5 months

First QC Date

August 30, 2014

Last Update Submit

March 4, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • all-cause mortality

    30 days

Secondary Outcomes (9)

  • duration of organ support

    30 days

  • Efficacy as measured by frequency of treated infectious and noninfectious complications

    30 days

  • Efficacy as measured by frequency of Vomiting

    30 days

  • Efficacy as measured by frequency of Diarrhea

    30 days

  • Efficacy as measured by frequency of Abdominal distention or Cramping

    30 days

  • +4 more secondary outcomes

Study Arms (2)

EN group

PLACEBO COMPARATOR

5% glucose at a rate of 25 mL/h was given at day 1, followed with initial amount of EN (31.25g peptisorb dissolved in 250ml water) at 12.5 mL/h on day 2. From day 3 to day 6, the prescription is EN (62.5g peptisorb dissolved in 250ml water) at 12.5 mL/h. Since day 7, EN was began to advance to goal energy target as quickly as possibl

PEC/EN group

EXPERIMENTAL

An additional amount of pectin was added 4 hours ahead of EN given from day 2 to day 6 (24g everday). Since day 7, EN was advanced to goal energy target as the same step

Drug: pectin

Interventions

pectinDRUG

Pectin, a representative diety fibre, is a gelatinous substance derived from the cell walls of fruits and some plants and contains galacturonan, consisting of mostly long-chain D-galacturonic acids combined into units by α-1,4 linkages. As a kind of soluble dietary fiber, pectin has been proved of controlling glucose and blood lipids. It slows rapid infusion of the liquid meal into the gut by delaying gastric emptying.

PEC/EN group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult ICU patients who were at least 18 years old if they were expected to require EN support within 36 hours after an unplanned ICU admission.

You may not qualify if:

  • Could not be fed through enteral route,
  • Had received EN in the past 2 months,
  • Had a colectomy or jejunostomy in situ,
  • Had severe colonic disease such as ulcerative colitis and Crohn's,
  • Had pregnant,
  • Had EN taboo crowd.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Nutrition DisordersCritical Illness

Interventions

Pectins

Condition Hierarchy (Ancestors)

Nutritional and Metabolic DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

BiopolymersPolymersMacromolecular SubstancesPolysaccharidesCarbohydratesPlant ExtractsPlant PreparationsBiological ProductsComplex Mixtures

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

August 30, 2014

First Posted

March 5, 2015

Study Start

August 1, 2014

Primary Completion

January 1, 2015

Study Completion

January 1, 2015

Last Updated

March 5, 2015

Record last verified: 2015-02